We investigated whether the addition of adjuvant chemotherapy to chemoradiation improves
overall survival (OS) and progression-free survival (PFS) by conducting a systematic review …

Background Locally advanced cervical cancer (LACC) is generally treated using concurrent
chemo-radiotherapy (CCRT); yet, the effectiveness of adjuvant chemotherapy (ACT) …

Cisplatin resistance is a major challenge in cervical cancer (CC) chemotherapy. Growth
arrest‐specific 5 (GAS5) has been reported to be a tumour suppressor gene in CC …

Purpose: To investigate the anti-cancer, chemosensitizing and/or immunomodulating effects
of decitabine (DAC) to be used as a potential therapeutic agent for the treatment of cervical …

Simple Summary The standard of care for locally advanced cervical cancer is
chemoradiation and brachytherapy. The addition of adjuvant systemic treatment may …

Objectives To build radiomics based OS prediction tools for local advanced cervical cancer
(LACC) patients treated by concurrent chemoradiotherapy (CCRT) alone or followed by …

Findings on the efficacy of adjuvant chemotherapy (ACT) of locally advanced cervical cancer
(LACC) after the concurrent chemoradiation (CCRT) therapy were inconsistent, and the …

Objective The present analysis determined the disease free survival (DFS) and overall
survival (OS) at up to 14 years of follow-up in women who participated in our previous phase …

Objective Accumulated evidence has suggested a relatively high recurrence rate in early-
stage cervical cancer (CC) patients with risk factors. This study aimed to assess the efficacy …

Objective This study aimed to assess the efficacy and safety of adjuvant chemotherapy
(ACT) after concurrent chemoradiation (CCRT) in patients with locally advanced cervical …